A trusted partner of leading pharmaceutical companies at a global level
Leverage Aptar Digital Health’s user communities to run virtual studies and generate real-world insights on treatment usage.
Aptar Digital Health has built and manages large, engaged digital communities across multiple therapeutic areas. These communities enable pharmaceutical companies and research partners to better understand patient experiences, support virtual study execution, and generate insights on real-world treatment usage, within secure and compliant frameworks.
Migraine Buddy® is a widely used mobile application supporting people living with migraine and headache disorders. The app enables users to track symptoms, triggers, and treatments, helping them better understand and communicate their condition.
With a global community of more than 4 million of users in 132 countries, Migraine Buddy® contributes to migraine awareness and supports scientific research by enabling engagement with relevant patient populations for clinical and academic studies.
Learn more
Esme is a digital companion designed for people living with multiple sclerosis. Esme is built around three core pillars:
Allergy Buddy is designed to help people living with allergic rhinitis and seasonal allergies feel more in control of their day. The app combines real-time pollen and weather insights with easy symptom tracking and personalized tips, making allergy management simple, proactive, and empowering. With Allergy Buddy, users can:
Learn more
From secure and compliant patient enrollment to patient-centered engagement strategies, our solutions are designed to support data entry and quick reconciliation. Our virtual study services focus on maintaining participant engagement and reliable data collection throughout the study lifecycle, helping to reduce timelines while preserving data quality. We ensure up to 97% completion rate in our virtual trial service, we ensure high participant adherence and engagement throughout the study.
By leveraging our users communities, we help pharma companies to run virtual studies, improving efficiency, accuracy, and predictability.
Ensure that only eligible participants are enrolled in your study through thorough and compliant medical screening processes, including questionnaires and screening visits, which can be conducted remotely or face-to-face.
Leverage targeted strategies to efficiently recruit the right participants for your study. This includes accelerated recruitment completed 6 months ahead of schedule, creation of recruitment materials, patient communication, and real-time recruitment dashboards.
Maintain the integrity and quality of your study with continuous monitoring, ensuring adherence to protocols and regulatory requirements. Maintain the integrity and quality of your study with continuous monitoring, ensuring adherence to protocols and regulatory requirements.
Implement patient-centered approaches to keep participants engaged and motivated throughout the study, reducing dropout rates.
Utilize advanced tools to track the progress of your study in real-time, allowing for timely adjustments and interventions.
<!– wp:acf/apt-bt {“name”:”acf/apt-bt”,”data”:{“field_64a62af175244”:{“row-0”:{“field_64a62844b1b40″:”bg_white”,”field_64a62a7db1b41″:”0″,”field_64a62837b1b3f”:{“title”:”Request a demo “,”url”:”https://aptardigitalhealth.com/contact-us/”,”target”:”_blank”}}},”field_64a62a90b1b42″:{“title”:””,”url”:””,”target”:””}},”mode”:”edit”} /–>Ensure high-quality data collection, entry, and reconciliation with robust data management solutions, facilitating accurate and reliable study outcomes.
Looking to reduce risk and timelines for your next study? Discover how Aptar Digital Health has supported clients by leveraging patient communities and advanced analytics to identify eligible participants earlier, accelerate recruitment, and sustain engagement.
Beyond studies, our user communities generate valuable real-world data that can help deepen understanding of patient experiences, treatment usage patterns, and unmet needs.
Gain insights into how treatments are used in real-life settings across diverse patient populations to possibly allow addition of new claims.
Leverage anonymized, aggregated data to explore usage patterns, patient experience trends, and disease burden at scale, supporting research, strategy, and lifecycle planning.
Reaching new patients is a critical need for the current competitive pharma landscape. Engage with our users’ communities to target a specific audience, get insights on specific questions and to acquire new users.
Migraine Buddy® is a widely used mobile application supporting people living with migraine and headache disorders. The app enables users to track symptoms, triggers, and treatments, helping them better understand and communicate their condition.
With a global community of more than 4 million of users in 132 countries, Migraine Buddy® contributes to migraine awareness and supports scientific research by enabling engagement with relevant patient populations for clinical and academic studies.
Learn more
Esme is a digital companion designed for people living with multiple sclerosis. Esme is built around three core pillars:
Whether you are planning a virtual study or exploring real-world data opportunities, our teams can help you define an approach aligned with your scientific and operational goals.